Intermediate term results for iodine 125 brachytherapy for favorable risk prostate cancer

被引：0
|
作者：
Crook, J. M. [1 ]
Yeung, I. [1 ]
Gillan, C. [1 ]
McLean, M. [1 ]
Lockwood, G. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.622
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2216
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [1] Intermediate term results for iodine 125 brachytherapy for favourable risk prostate cancer for 556 patients
    Crook, J.
    Yeung, I.
    Gillan, C.
    McLean, M.
    Lockwood, G.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S42 - S42
  • [2] Long-term results of Iodine-125 seed brachytherapy in low and intermediate risk prostate carcinoma
    Guinot, J.
    Gonzalez-Perez, V.
    Casanova, J.
    Santos, M. A.
    De los Dolores, V.
    La Rosa, A.
    Sanchez-Rodriguez, A.
    Laborda, A.
    Canos, S.
    Cotanda, V.
    Guardino, C.
    Tortajada, M. I.
    Arribas, L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S497 - S498
  • [3] Iodine 125 brachytherapy for favorable risk prostate cancer: Results for 509 patients. When can we start to trust PSA after brachytherapy?
    Crook, JM
    Gillan, C
    Yeung, I
    McLean, M
    Lockwood, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S296 - S296
  • [4] Permanent iodine-125 seed brachytherapy for low and intermediate risk prostate cancer: 13 year results at a single australian institution
    Bece, A.
    Malouf, D.
    Chin, Y.
    Papadopoulos, B.
    Fisher, L.
    Enari, K.
    Thomson, P.
    Bucci, J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 10 - 10
  • [5] Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer
    Stone, NN
    Stock, RG
    Unger, P
    JOURNAL OF UROLOGY, 2005, 173 (03): : 803 - 807
  • [6] Iodine 125 brachytherapy for prostate cancer in Ravenna (Italy)
    Del Duca, M
    Palazzi, S
    Emiliani, E
    Giannini, M
    Dal Pozzo, C
    Di Stefano, C
    Severini, G
    Gnani, G
    Mazzotti, G
    Morelli, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S101 - S101
  • [7] Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer
    Guinot, Jose Luis
    Casanova, Juan
    Gonzalez-Perez, Victor
    Santos, Miguel Angel
    Dolores, Victor De los
    Tortajada, Maria Isabel
    Guardino, Carmen
    Crispin, Vicente
    Rubio-Briones, Jose
    Arribas, Leoncio
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (03) : 215 - 221
  • [8] Permanent prostate brachytherapy for intermediate risk prostate cancer
    Frazier, AJ
    Keole, SR
    Forman, JD
    Cher, M
    Zuniga, C
    Rosemberg, S
    RADIOLOGY, 2002, 225 : 266 - 267
  • [9] Long term urinary sequelae following iodine 125 prostate brachytherapy
    Crook, J.
    Fleshner, N.
    Roberts, C.
    Pond, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S16 - S16
  • [10] Prostate brachytherapy with permanent iodine (125I) seed implant (LDR) - intermediate biochemical results and complications
    Harza, M.
    Dudu, C.
    Iordache, A.
    Voinea, S.
    Pavel, C.
    Gingu, C.
    Serbanescu, B.
    Chibelean, C.
    Surcel, C.
    Preda, A.
    Baston, C.
    Stefan, B.
    Haineala, B.
    Anghel, R.
    Vasile, M.
    Domnisor, L.
    Rebegea, L.
    Radulescu, M. F.
    Sinescu, I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 688 - 688
12345